41060:CANCER ANTIGEN 15-3 (CA15-3)
Author PeaceHealth Laboratories
 Print View Attached Docs: |
| Alias Names: |
CA15-3 |
| Methodology: |
Chemiluminescent Immunoassay (CLIA) |
| Edit Date: |
12/10/2009 |
| Performed: |
Daily |
| Released: |
Same day as tested |
| CPT Code: |
86300 |
| Specimen Collection Details |
| Collection: |
One 7.5 mL serum separator tube (SST). |
| Handling: |
Allow to clot, centrifuge and immediately separate serum from cells. Refrigerate. Freeze if specimen cannot be assayed within 7 days. Allow no more than one freeze/thaw cycle. Social Security Number must be provided if historical graph is to be reported. |
| Stability: |
7 days refrigerated or 1 year frozen. Unstable ambient. |
| Standard Volume: |
1 mL serum. |
| Minimum Volume: |
0.5 mL serum. |
| Transport: |
Refrigerated, or if frozen, on dry ice. |
| Comments: |
Serum levels of this antigen are utilized for patients with breast cancer. |
| Rejection Criteria: |
More thatn one freeze/thaw cycle.
MEDICARE MAY REQUIRE A SIGNED ADVANCE BENEFICIARY NOTICE (ABN) FOR THIS TEST |